Clear Harbor Asset Management’s Sanofi Contingent Value Rights GCVRZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-15,635
| Closed | -$13.4K | – | 803 |
|
|
2019
Q4 | $13.4K | Hold |
15,635
| – | – | ﹤0.01% | 577 |
|
|
2019
Q3 | $9K | Hold |
15,635
| – | – | ﹤0.01% | 259 |
|
|
2019
Q2 | $8K | Hold |
15,635
| – | – | ﹤0.01% | 249 |
|
|
2019
Q1 | $7K | Hold |
15,635
| – | – | ﹤0.01% | 246 |
|
|
2018
Q4 | $8K | Sell |
15,635
-18,000
| -54% | -$8.94K | ﹤0.01% | 238 |
|
|
2018
Q3 | $17K | Hold |
33,635
| – | – | ﹤0.01% | 253 |
|
|
2018
Q2 | $17K | Hold |
33,635
| – | – | ﹤0.01% | 254 |
|
|
2018
Q1 | $14K | Hold |
33,635
| – | – | ﹤0.01% | 232 |
|
|
2017
Q4 | $13K | Hold |
33,635
| – | – | ﹤0.01% | 243 |
|
|
2017
Q3 | $12K | Hold |
33,635
| – | – | ﹤0.01% | 241 |
|
|
2017
Q2 | $13K | Hold |
33,635
| – | – | ﹤0.01% | 252 |
|
|
2017
Q1 | $15K | Hold |
33,635
| – | – | ﹤0.01% | 249 |
|
|
2016
Q4 | $13K | Hold |
33,635
| – | – | ﹤0.01% | 249 |
|
|
2016
Q3 | $9K | Hold |
33,635
| – | – | ﹤0.01% | 249 |
|
|
2016
Q2 | $8K | Hold |
33,635
| – | – | ﹤0.01% | 259 |
|
|
2016
Q1 | $4K | Hold |
33,635
| – | – | ﹤0.01% | 251 |
|
|
2015
Q4 | $4K | Hold |
33,635
| – | – | ﹤0.01% | 271 |
|
|
2015
Q3 | $6K | Hold |
33,635
| – | – | ﹤0.01% | 275 |
|
|
2015
Q2 | $24K | Hold |
33,635
| – | – | ﹤0.01% | 303 |
|
|
2015
Q1 | $23K | Hold |
33,635
| – | – | ﹤0.01% | 299 |
|
|
2014
Q4 | $27K | Hold |
33,635
| – | – | 0.01% | 280 |
|
|
2014
Q3 | $16K | Hold |
33,635
| – | – | ﹤0.01% | 213 |
|
|
2014
Q2 | $17K | Hold |
33,635
| – | – | ﹤0.01% | 230 |
|
|
2014
Q1 | $10K | Buy |
+33,635
| New | +$12.5K | ﹤0.01% | 210 |
|
Clear Harbor Asset Management's GCVRZ Position: Q1 2020 in Review
Clear Harbor Asset Management sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 15,635 shares — an estimated $13.4K sold.
Clear Harbor Asset Management first reported a position in GCVRZ in Q1 2014 and held it in 24 quarters. The position peaked at $27K in Q4 2014. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.
- Clear Harbor Asset Management reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
- Clear Harbor Asset Management sold 15,635 Sanofi Contingent Value Rights shares in Q1 2020, an estimated $13.4K.
- Clear Harbor Asset Management first reported a position in Sanofi Contingent Value Rights in Q1 2014 and held it in 24 quarters.
- Clear Harbor Asset Management's Sanofi Contingent Value Rights position peaked at $27K in Q4 2014.
- 2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.
Based on Clear Harbor Asset Management's 13F filing for Q1 2020, filed 8 May 2020.